PARK2 copy number aberrations in two children presenting with autism spectrum disorder: Further support of an association and possible evidence for a new microdeletion/microduplication syndrome
Identifieur interne : 000216 ( Main/Exploration ); précédent : 000215; suivant : 000217PARK2 copy number aberrations in two children presenting with autism spectrum disorder: Further support of an association and possible evidence for a new microdeletion/microduplication syndrome
Auteurs : Angela Scheuerle [États-Unis] ; Kathleen Wilson [États-Unis]Source :
- American Journal of Medical Genetics Part B: Neuropsychiatric Genetics [ 1552-4841 ] ; 2011-06.
English descriptors
- KwdEn :
Abstract
Microdeletions of PARK2 have been reported previously in seven patients with autism spectrum disorder. There are no reports of PARK2 microduplications in this population. Presented are two patients, one with deletion and the other with duplication, both with autism spectrum disorder, though their syndromic phenotypes vary. The deletion patient is cognitively normal and ectomorphic: the duplication patient is cognitively impaired, underweight and short. Further, the microduplication patient has demonstrated adverse medication reactions to psychotropic medications active in the dopamine metabolic pathway: cyclopentolate, lisdexamfetamine, methylphenidate. These patients support an association between PARK2 mutations and autism spectrum disorder and suggest that duplications may be equally causative. It is hypothesized that the disparate patient phenotypes may represent a deletion/duplication syndrome and that the adverse medication reactions may be a pharmacogenetic phenomenon. © 2011 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/ajmg.b.31176
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">PARK2 copy number aberrations in two children presenting with autism spectrum disorder: Further support of an association and possible evidence for a new microdeletion/microduplication syndrome</title><author><name sortKey="Scheuerle, Angela" sort="Scheuerle, Angela" uniqKey="Scheuerle A" first="Angela" last="Scheuerle">Angela Scheuerle</name></author><author><name sortKey="Wilson, Kathleen" sort="Wilson, Kathleen" uniqKey="Wilson K" first="Kathleen" last="Wilson">Kathleen Wilson</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:217DE7A9BB92583255DB7E418515558EED2936AF</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/ajmg.b.31176</idno><idno type="url">https://api.istex.fr/document/217DE7A9BB92583255DB7E418515558EED2936AF/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000972</idno><idno type="wicri:Area/Main/Curation">000845</idno><idno type="wicri:Area/Main/Exploration">000216</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">PARK2 copy number aberrations in two children presenting with autism spectrum disorder: Further support of an association and possible evidence for a new microdeletion/microduplication syndrome</title><author><name sortKey="Scheuerle, Angela" sort="Scheuerle, Angela" uniqKey="Scheuerle A" first="Angela" last="Scheuerle">Angela Scheuerle</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>Tesserae Genetics, Dallas</wicri:cityArea></affiliation></author><author><name sortKey="Wilson, Kathleen" sort="Wilson, Kathleen" uniqKey="Wilson K" first="Kathleen" last="Wilson">Kathleen Wilson</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Texas</region></placeName><wicri:cityArea>McDermott Center for Human Growth and Development, University of Texas Southwestern, Dallas</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</title><title level="j" type="abbrev">Am. J. Med. Genet.</title><idno type="ISSN">1552-4841</idno><idno type="eISSN">1552-485X</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-06">2011-06</date><biblScope unit="volume">156</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="413">413</biblScope><biblScope unit="page" to="420">420</biblScope></imprint><idno type="ISSN">1552-4841</idno></series><idno type="istex">217DE7A9BB92583255DB7E418515558EED2936AF</idno><idno type="DOI">10.1002/ajmg.b.31176</idno><idno type="ArticleID">AJMG31176</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1552-4841</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>6q26</term><term>asperger</term><term>chromosome 6</term><term>parkinsonism</term><term>pharmacogenetic</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Microdeletions of PARK2 have been reported previously in seven patients with autism spectrum disorder. There are no reports of PARK2 microduplications in this population. Presented are two patients, one with deletion and the other with duplication, both with autism spectrum disorder, though their syndromic phenotypes vary. The deletion patient is cognitively normal and ectomorphic: the duplication patient is cognitively impaired, underweight and short. Further, the microduplication patient has demonstrated adverse medication reactions to psychotropic medications active in the dopamine metabolic pathway: cyclopentolate, lisdexamfetamine, methylphenidate. These patients support an association between PARK2 mutations and autism spectrum disorder and suggest that duplications may be equally causative. It is hypothesized that the disparate patient phenotypes may represent a deletion/duplication syndrome and that the adverse medication reactions may be a pharmacogenetic phenomenon. © 2011 Wiley‐Liss, Inc.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region></list><tree><country name="États-Unis"><region name="Texas"><name sortKey="Scheuerle, Angela" sort="Scheuerle, Angela" uniqKey="Scheuerle A" first="Angela" last="Scheuerle">Angela Scheuerle</name></region><name sortKey="Wilson, Kathleen" sort="Wilson, Kathleen" uniqKey="Wilson K" first="Kathleen" last="Wilson">Kathleen Wilson</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000216 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000216 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:217DE7A9BB92583255DB7E418515558EED2936AF
|texte= PARK2 copy number aberrations in two children presenting with autism spectrum disorder: Further support of an association and possible evidence for a new microdeletion/microduplication syndrome
}}
| This area was generated with Dilib version V0.6.23. |  |